We previously showed that disruptions in TGF-β signaling, coupled with loss of the SMAD adaptor SPTBN1, resulted in the spontaneous development of multiple tumors and a high incidence of liver cancer in human fibroblast and mouse models [20]. This evidence concerns the gene SPTBN1 and liver cancer.